Skip to content

A clinical registry to monitor outcomes of shoulder and elbow pathology

A clinical quality registry to monitor outcomes of shoulder and elbow pathology among private patients referred to an orthopaedic clinic

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12617000864325
Acronym
CROSEP
Enrollment
2990
Registered
2017-06-13
Start date
2017-07-24
Completion date
2020-02-05
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The proposed registry is necessary to monitor the natural history of shoulder pathologies occurring in the general population and to monitor short-term and long-term patient outcomes associated with the condition and contemporary treatment options. The aim of the registry is to objectively assess patient-centred outcomes of definitive management for shoulder and elbow pathologies. Patients will be enrolled in an opt-out clinical registry (longitudinal observational design) hosted by the clinic providing diagnosis and treatment of their condition. Patient outcomes, clinical imaging, joint function, as well as treatment and clinical information will be collected as part of standard of care and collated into an electronic registry maintained at the clinic. Patients will be monitored for up to 5years after definitive treatment.

Interventions

Patients presenting with pathologies of the shoulder or elbow and referred to specialist orthopaedic review. 1. Patients diagnosed with either a recent shoulder dislocation or clinically defined glenohumeral instability: Treated with non-operative management or surgical stabilisation. Followed for a duration of 2 years. 2. Patients diagnosed with rotator cuff pathology (subacromial impingement; tendinopathy; tear): Treated with non-operative management or surgical repair. Followed for a durati

Patients presenting with pathologies of the shoulder or elbow and referred to specialist orthopaedic review. 1. Patients diagnosed with either a recent shoulder dislocation or clinically defined glenohumeral instability: Treated with non-operative management or surgical stabilisation. Followed for a duration of 2 years. 2. Patients diagnosed with rotator cuff pathology (subacromial impingement; tendinopathy; tear): Treated with non-operative management or surgical repair. Followed for a duration of 2 years. 3. Patients diagnosed with acromioclavicular instability of any aetiology: Treated with non-operative management or surgical stabilisation. Followed for a duration of 2 years. 4. Patients diagnosed with glenohumeral arthritis of any aetiology: Treated with non-operative management, arthroscopic surgery or total shoulder arthroplasty. Followed for a duration of 5 years. 5. Patients diagnosed with acute fracture of the scapula, clavicle or humerus (including associated glenohumeral dislocation): Treated with non-operative management, internal fixation or total shoulder arthroplasty. Followed for a duration of 2 years. 6. Patients diagnosed with frozen shoulder, prominent hardware of the shoulder, prosthesis issues, extrinsic tendon injury or neuological injury affecting the shoulder: Managed non-operatively or treated surgically (arthroscopic or open repair). Followed for a duration of 2 years. 7. Patients with a primary diagnosis invloving the elbow (including arthritis, fracture, tendon/ligament injury or instability event): Managed non-operatively or treated surgically (stabilisation, repair or internal fixation). Followed for a duration of 2 years.

Sponsors

Mr Harry Clitherow
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
7 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients presenting for diagnosis and treatment to one of the participating orthopaedic surgeons as a private patient (private insured, public uninsured as a private patient)

Exclusion criteria

- Elects to opt-out of the registry - Suffers from a neurological, psychological pathology that precludes them from providing patient feedback on treatment outcomes - unable to provide informed consent to treatment

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026